Cost-Effectiveness of Evolocumab Therapy for Myocardial Infarction: The Chinese Healthcare Perspective
Zhe Liang, Qi Chen, Fei Yang, Xianliang Yan, Xuehui Zhang, Chen Xue, Fang Fang, Quanming Zhao
Topics & Concepts
EvolocumabMedicinePCSK9PopulationQuality-adjusted life yearPlaceboCost effectivenessMyocardial infarctionCohortInternal medicineCholesterolApolipoprotein BLipoproteinEnvironmental healthAlternative medicineRisk analysis (engineering)LDL receptorPathologyApolipoprotein A1Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesCoronary Interventions and Diagnostics